{'fraction_non_alphanumeric': 0.031486146095717885, 'fraction_numerical': 0.0163727959697733, 'mean_word_length': 4.719424460431655, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Improving the Prediction of Recurrence of Node‐Negative Breast Cancer

“The problem we’re facing in the area of node-negative breast cancer is that the disease has a five-year recurrence rate of 13% and a death rate of 11%,” said Timothy E. Kute, PhD, Associate Professor of Pathology and Cancer Biology at Wake Forest University Baptist Medical Center in WinstonSalem, NC. “Patients with node-negative breast cancer are doing pretty well. But what do you do knowing you have a chance of recurrence? We need to figure out what patients have a higher chance of recurrence and those who don’t.” Basing treatment on markers indicating that the chance of recurrence is less than 5% would help oncologists Improving the Prediction of Recurrence of Node-Negative Breast Cancer PAGE 44 / JULY 10, 2004